» Authors » W H Lyness

W H Lyness

Explore the profile of W H Lyness including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 284
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sachdeo R, Wagner M, Sachdeo S, Shumaker R, Lyness W, Rosenberg A, et al.
Epilepsia . 1999 Aug; 40(8):1122-8. PMID: 10448826
Purpose: This open-label study investigated the pharmacokinetic interaction of phenytoin (PHT) and felbamate (FBM). Methods: Ten subjects with epilepsy receiving PHT monotherapy were administered increasing doses of FBM (1,200, 1,800,...
2.
Sachdeo R, Montgomery P, Shumaker R, Perhach J, Lyness W, Rosenberg A
J Clin Pharmacol . 1998 Apr; 38(2):184-90. PMID: 9549651
Effects of erythromycin on hepatic CYP450 3A4 isozymes can profoundly influence the metabolism of many therapeutic agents. An open-label, randomized, two-period, crossover study was therefore conducted to evaluate the pharmacokinetics...
3.
Morganroth J, Lyness W, Perhach J, Mather G, Harr J, TRAGER W, et al.
J Clin Pharmacol . 1998 Mar; 37(11):1065-72. PMID: 9506001
Azelastine, an antihistamine with additional pharmacologic properties, was evaluated for a possible influence on pharmacokinetic and electrocardiographic parameters due to its coadministration with CYP3A4 inhibitor ketoconazole (200 mg every 12...
4.
Sachdeo R, Shumaker R, Perhach J, Lyness W, Rosenberg A
Epilepsia . 1997 Aug; 38(8):887-92. PMID: 9579889
Purpose: Felbamate (FBM) pharmacokinetic parameters, safety and tolerability in the dose range of 1,200-6,000 mg/day were assessed in two open-label studies with similar designs. Methods: In study A, newly diagnosed...
5.
Kurth M, Tetrud J, Irwin I, Lyness W, Langston J
Neurology . 1993 May; 43(5):1036-9. PMID: 8492922
Four patients with Parkinson's disease, optimally treated with levodopa/carbidopa (LD/CD) tablets but experiencing severe motor fluctuations, underwent an open trial of a levodopa/carbidopa/ascorbic acid solution (LCAS) orally at timed intervals....
6.
Lyness W, Smith F
Pharmacol Biochem Behav . 1992 May; 42(1):187-92. PMID: 1388276
Rats implanted with chronic indwelling intravenous catheters and allowed access to a self-administration apparatus learned to self-inject intravenous ethanol. Ethanol concentrations of 0.5, 1.0, and 2.0%, corresponding to a dose/injection...
7.
Lyness W, Smith F, Heavner J, Iacono C, Garvin R
Life Sci . 1989 Jan; 45(23):2217-24. PMID: 2601574
Rats injected with Freund's adjuvant develop a syndrome resembling human rheumatoid arthritis complete with paw swelling, edema and persistent pain. At the onset of pain, arthritic rats and their pain-free...
8.
Smith F, St John C, Yang T, Lyness W
Psychopharmacology (Berl) . 1989 Jan; 97(4):501-6. PMID: 2567031
Biochemical, electrophysiological, and behavioral experiments suggest that the dopamine D-1 and D-2 receptor subtypes functionally interact. In rats trained to discriminate 1.0 mg/kg d-amphetamine, substitution with the D-2 agonist quinpirole...
9.
Leccese A, Lyness W
Neuropharmacology . 1987 Sep; 26(9):1303-8. PMID: 3118232
It has been suggested that dopamine (DA)-containing neurons within the medial prefrontal cortex subserve a role in the positive reinforcing effects of psychomotor stimulants. Injections of 6-hydroxydopamine (6-OHDA) into this...
10.
Geis L, Smith D, Smith F, Yu D, Lyness W
Pharmacol Biochem Behav . 1986 Nov; 25(5):1027-33. PMID: 3786355
Earlier work had shown that L-tyrosine administration, precursor to both dopamine (DA) and norepinephrine (NE), could increase brain DA metabolite concentrations after amphetamine treatment and restore amphetamine-induced decreases in whole...